Zileuton, a specific inhibitor of 5-lipoxygenase, is used to treat asthma but was shown to reduce Aβ, tau phosphorylation, and delay the onset of cognition impairments in mouse models of AD [139]. This evidence concerns the gene MAPT and Alzheimer disease.